Download as pdf or txt
Download as pdf or txt
You are on page 1of 5

Materials Letters 211 (2018) 43–47

Contents lists available at ScienceDirect

Materials Letters
journal homepage: www.elsevier.com/locate/mlblue

Biogenic synthesis, characterization, acute oral toxicity studies of


synthesized Ag and ZnO nanoparticles using aqueous extract of Lawsonia
inermis
N. Jayarambabu a, K. Venkateswara Rao a,⇑, V. Rajendar b,c,⇑,1
a
Centre for Nanoscience and Technology, Institute of Science and Technology, Jawaharlal Nehru Technological University Hyderabad, Telangana State 500085, India
b
Department of Physics, B.V. Raju Institute of Technology, Narsapur, Medak, Telangana State 502313, India
c
Department of Electronic Engineering, Yeungnam University, Gyeongsan-si, Gyeongsangbuk-do 38541, Republic of Korea

a r t i c l e i n f o a b s t r a c t

Article history: The Ag and ZnO nanoparticles are synthesized by a green method using Lawsonia inermis plant extract.
Received 3 August 2017 The phytochemical constituent (2-hydroxy-1, 4-napthoquionone) found in the leaf extract of Lawsonia
Received in revised form 19 September inermis plays an important role in the reduction and formation of Ag and ZnO nanoparticles. The biosyn-
2017
thesis of Ag and ZnO NPs was observed by the color change from colorless to dark brown and light brown.
Accepted 23 September 2017
Available online 23 September 2017
The FE SEM, TEM DLS analysis confirmed the average particle size of Ag and ZnO NPs as 100 nm, 20 nm,
28.5 nm and 100 nm, 20 nm, 38.4 nm respectively. Crystalline nature and presence of Ag and ZnO NPs
were confirmed by XRD. The FT-IR spectra of the Ag and ZnO authorized the presence of phyto con-
Keywords:
Biogenic synthesis
stituents as capping agent. From results of acute oral toxicity studies, it was found that Ag and ZnO
Lawsonia inermis NPs at 2000 mg/kg b.w have shown no mortality during the treatment period. The present study revealed
Nanoparticles the safer use of eco-friendly green synthesized Ag and ZnO NPs in the field of nano-biomedicine.
Biomaterials Ó 2017 Elsevier B.V. All rights reserved.
Acute oral toxicity studies

1. Introduction fic surface area compared to chemical route synthesized nanopar-


ticles [10–12]. The more research is needed to improve the
Nanotechnology, especially nanomaterials research has been production and application of green method synthesized nanopar-
developing rapidly due to potential applications in numerous ticles [13]. The Ag and ZnO NPs were known to be effective against
areas, including biomedical, magnetics sciences, biosensors, opto- bacterial and viral mediated diseases and possess a huge potential
electronics, catalysis and shown to be a promising antimicrobial in treating various diseases like revascularization, retinal, cancer,
agent. The green synthesis of nanoparticles has acquired interest diabetes, hepatitis B, acquired human immunodeficiency
as a relatively, sustainable, and environmentally eco-friendly syndrome (AIDS), etc in the near future. The present work aims
method for the production of nanoparticles [1–7]. The rationale in synthesis of Ag and ZnO NPs using Lawsonia inermis and to
behind the use of plant leafs and fruits for the synthesis of Ag explore its toxicity studies.
and ZnO NPs are not only because the method is simple, easy
and faster but the synthesized particles were also stable, capped
2. Synthesis of silver and zinc oxide nanoparticles
by the biological compounds, reliable and cost effective than other
conventional methods [7–9]. The green method processes can
All the chemicals used in this method were analytical grade and
make use of plant or fruit extracts, enzymes, bacterial extracts,
used as received without any further purification.
fungi and replace dangerous chemicals. Green method NPs have
been shown to exhibit higher catalytic reactivity and greater speci-
2.1. Lawsonia inermis plant leaf extract

⇑ Corresponding authors at: Department of Electronic Engineering, Yeungnam The Lawsonia inermis plant used in this experiment were pro-
University, Gyeongsan-si, Gyeongsangbuk-do 38541, Republic of Korea
vided from a local garden in JNTUH campus. 50 g of fresh leaves
(V. Rajendar).
E-mail addresses: kalagadda2003@gmail.com (K.V. Rao), rajendar.nano@gmail.
were washed several times for removing any adherent particles,
com (V. Rajendar). and placed in the beaker to heat at 80 °C for 40 min. Filtered the
1
http://orcid.org/0000-0002-2049-5085. solution with the help of whataman filter paper.

https://doi.org/10.1016/j.matlet.2017.09.082
0167-577X/Ó 2017 Elsevier B.V. All rights reserved.
44 N. Jayarambabu et al. / Materials Letters 211 (2018) 43–47

2.2. Synthesis of Ag nanoparticles groups received 2000 mg/kg b.w of Ag and ZnO nanoparticles.
The ZnO NPs do not affect the acute oral toxicity and the
The 0.5 g of AgNO3 precursor dissolved in 50 ml water and the histopathological study. The biological synthesized ZnO NPs has
filtrate of Lawsonia inermis leaf extract was added and stirred for shown small particle size of NPs creates a large surface area per
60 min at 50 °C. After stirring the system was maintained to room unit mass. In this study 2000 mg/kg concentration of ZnO Nanopar-
temperature and the precipitate was collected. Finally the precipi- ticles synthesized using Lawsonia inermis leaf extract has not
tate was washed with absolute ethanol for several times and dried induced any toxicity during the treatment period. Immediately
in vacuum condition at 70 °C for 24 h. after administration of dose, the mice were observed for the first
4 h for skin and fur changes, eye secretion, respiration, any behav-
2.3. Synthesis of ZnO nanoparticles ioral changes and death, if any, intermittently for the next 6 h, then
again at 24 h after dosing. Special attention was paid on the clinical
50 ml of filtered Lawsonia inermis leaf aqueous extract and 2 g signs of toxicity including convulsions, tremors, salivation, nausea,
Zn(NO3)2 6H2O was dissolved. The salt was completely dissolved vomiting, diarrhea, lethargy, coma, etc. They were then kept under
in aqueous extract without any additional heat treatment. The observation up to 14 days to identify mortality, if any. The observa-
mixtures were covered with aluminium foil to avoid any photoin- tions were made daily. In addition, the histopathological changes
duced phenomenon and kept at room temperature. The color have been examined as well [14]. After 2 weeks, mice were sacri-
change observed after 1 h, precipitate suggesting the formation ficed by cervical dislocation, tissues were collected and kept in
of a zinc oxide complex in suspension. The mixture compound 10% formalin solution and subjected for histopathology study [15].
was dried at 120 °C in a oven, the powder was collected and
washed several times with distilled water to remove any residue 3. Results and discussion
of the extract. The obtained product was subjected to an additional
heat treatment in air at 200 °C for 2 h. The number of braggs reflections can be seen with 2 theta val-
ues of 38.6, 42.8, 62.7 and 78.3 corresponding to the lattice planes,
2.4. Acute oral toxicity studies which may be indexed to the (1 1 1), (2 0 0), (2 2 0) and (2 2 2) of
Ag NPs respectively [16]. The calculated average crystalline size
The experiments were carried out according to the guidelines of for Ag NPs is found to be 16 nm, which is close to the average par-
the Committee for the Purpose of Control and Supervision of ticle size of 20 nm obtained from TEM analysis. The crystal struc-
Experiments on Animals (CPCSEA), New Delhi, India on either sex ture of synthesized ZnO NPs was investigated by powder X-ray
of Swiss albino mice weighing 20–25 g. The study was conducted diffraction analysis. The XRD patterns of pure ZnO calcinated at
after getting approval from the Institutional animal ethical com- 200 °C for 4 h. the peaks at 31.82, 65.4, 36.6, 47.7, 62.9, 66.30,
mittee of CMR College of pharmacy, Hyderabad (approval no.: 67.5, 69.3 and 78.4 indexed to the (1 0 0), (0 0 2), (1 0 1), (1 0 2),
IAEC/1657/CMRCP/T2/PhD-16/47). The selected Swiss albino mice (1 1 0), (1 0 3), (1 1 2) and (2 0 1) crystal planes of ZnO respec-
were divided into 3 groups of 3 animals in each. Test mice were tively. The average crystalline size of the sample was calculated
fasted for 4 h before dosing with free access to water only. The nor- using Scherrer equation. The average crystalline size of ZnO NPs
mal control group received distilled water (10 ml/kg) and the test calculated was found to be 24 nm.

Fig. 1. XRD analysis (A) Ag NPs, (B) ZnO NPS. FTIR spectra (A) Ag NPs, (B) ZnO NPs & UV–Vis (A) Ag NPs, (B) ZnO NPs.
N. Jayarambabu et al. / Materials Letters 211 (2018) 43–47 45

The UV–Vis spectrum reveals the Ag nanoparticles formation by ZnO NPs. From FESEM morphological studies ZnO NPs we did not
exhibiting the typical Plasmon absorption at 458 nm which is indi- observed the spherical like structure it may be the plant compound
cating the presence of spherical Ag nanoparticles [17]. It also clar- coated on ZnO nanoparticles. DLS analysis showed that the Ag and
ified the formation of ZnO nanoparticles by showing absorption at ZnO NPs size was approximately 28.5 nm and 38.4 nm with low
382 nm. FT-IR analysis of Ag and ZnO NPs showed the intensive polydispersity index (PDI) of 0.035 and 0.028. The measured size
peaks at 3217.3 cm 1 to 1650 cm 1 (aromatic C–H, amide bond of particles by DLS was moderately similar as compared to the
of proteins due to carbonyl stretch in proteins), 1300–800 cm 1 TEM and XRD analysis. The zeta potential value of dispersed
(C–C bond of aromatic or amide group-II, C–N aromatic and biosynthesized Ag and ZnO NPs was – 42.7 mV and 39.9 mV typi-
aliphatic amines). The FT-IR spectrum of the biosynthesized Ag cally have degree of stability.
nanoparticles showed an absorption peak exhibited at wavenum-
ber 600–500 cm 1 which is associated to the stretching mode of 3.1. Acute oral toxicity and Histopathology studies
Ag nanoparticles. The ZnO nanoparticles peak exhibited at
570 cm 1 (Fig. 1). The animals appeared to be normal without any signs of toxic-
In order to investigate the morphology of the synthesized ity at a dose of 2000 mg/kg b.w administered orally and no mortal-
nanoparticles, FESEM images were recorded with different magni- ity was observed up to 14 days [20]. No gross physiological
fications. In Fig. 2 Ag nanoparticles with size of 100 nm are detect- changes were observed in control and Ag and ZnO NPs treated mice
able showing leaf like structures. In case of ZnO nanoparticle liver, brain, heart, and spleen. The liver hepatocytes appeared nor-
spherical structures were shown. mal with no signs of inflammation and necrosis in Control and Ag
The TEM image was taken for the characterization of the size and ZnO NPs treated mice (Fig. 3A–C). Brain didn’t show any
and structure of Ag & ZnO nanoparticles. Fig. 2 shown confirms abnormalities in astrocytes, nerve fibres and no demyelination
the very uniform spherical shape of Ag nanoparticles. The average were observed in treated mice (Fig. 3D–F). The Control, Ag & ZnO
particle size from TEM image was estimated to be 20 nm. In NPs treated Heart tissue showed normal cardiac fiber (Fig. 3G–I).
synthesis process the plant compounds of Linalool a-terpineol, The Spleen tissue showing normal lymphatic follicle size in both
EtherphenylvinylA 1,3-indandione, Eugenol, 2-hydroxy-1,4- Ag and ZnO NPs as that of control group (Fig. 3J–L). Acute oral tox-
napthoquionone, Oxirane-tetradecyl, Hexadecanoic acid. These icity and histopathological parameters were noted in Table 1. This
compounds present in the Lawsonia inermis plant they act as a study confirmed that Ag and ZnO NPs were nontoxic to the Liver,
capping agent and stabilizing agent. These factors mainly affect brain, heart, and spleen within the treatment durations. In this
on reduction and formation of the nanoparticles size. The TEM study Ag and ZnO nanoparticles were synthesized using Lawsonia
image of ZnO nanoparticles showed the spherical like structure inermis leaf extract. Which is a antioxidant, anti-inflammatory
with average size of 20 nm, which is inconsistent with that of and acts as liver tonic apart from other uses. The phytoconstituents
observed from FESEM images [18,19]. Due to the reason the Law- present in the extract are majorly acting as the reducing agent and
sonia inermis plant extract compounds coated on surface of the capping agent for synthesis of Ag and ZnO nanoparticles was very

Fig. 2. FESEM images (A) Ag NPs, (B) ZnO NPs & TEM images (A) Ag NPs, (B) ZnO NPs. PSA analysis (A) Ag NPs, (B) ZnO NPs and Zeta potential (A) Ag NPs, (B) ZnO NPs.
46 N. Jayarambabu et al. / Materials Letters 211 (2018) 43–47

Fig. 3. A, D, G & J indicates Control, B & C, E & F, H & I, K & L indicates Ag, ZnO treated liver, brain, heart & spleen respectively.

Table 1
Clinical parameters observed in control, Ag and ZnO NPs injected mice at 2000 mg/kg b.w.

S. Parameters Organ Control group 10 ml/kg Ag Nanoparticles treated 2000 mg/kg Zno Nanoparticles treated 2000 mg/
No kg
1 Histopathological Brain Normal brain tissues with astrocytes Normal brain tissues with astrocytes Normal brain tissues with astrocytes
changes and nerve fibres and nerve fibres and nerve fibres
2 Heart Normal cardiac fibre Normal cardiac fibre Normal cardiac fibre
3 Liver Normal liver with hepatocytes No inflammation in liver No inflammation in liver
4 Spleen Lymphatic follicles size appeared Lymphatic follicles size appeared Lymphatic follicles size appeared
normal normal normal
5 Clinical Skin and fur No change No change No change
abnormalities change
6 Urination Normal Normal Normal
7 Behavioral Tremors and Not observed Not observed Not observed
changes convulsions
8 Salivation Normal Normal Normal
9 Lethargy active active Active
10 Mortality Nil Nil Nil

safe so there is no inflammation seen in hepatocytes of liver of the observed in the heart of Ag & ZnO treated mice and is similar to
Ag and ZnO treated groups and looked similar to control group that of Control mice heart architecture. As the spleen is the direct
liver. So, from this study it was proved that the biogenic synthesis and indirect site for toxicity, there is no significant changes
of Ag and ZnO nanoparticles are non-toxic to any of the vital observed in the spleen lymphatic follicle tissue and no loss of cel-
organs. lularity was observed in both Ag and ZnO treated mice and is sim-
Acute toxicity studies do not detect effects on vital functions ilar to that of control mice spleen tissue indicating that the Ag and
like the cardiovascular, central nervous, and respiratory systems ZnO nanoparticles synthesized using Lawsonia inermis are non
and it is mainly performed to obtain an appropriate dose for phar- toxic from the histopathological study performed.
macological activity and to find out the affected organs at the end
of the treatment. From the histopathological images, it was
reported that the Ag and ZnO Nanoparticles synthesized using 4. Conclusion
Lawsonia inermis leaf extract has not induced any toxicity during
the treatment period. From the Ag and ZnO treated liver sectioning The achieved data revealed that Ag and ZnO NPs demonstrated
it was reported that the hepatocytes (the major mass of liver) are a high potential in toxicity studies. The size, surface area, crys-
without any inflammation and necrosis. If there is any inflamma- talline nature and the phytochemical present in the Lawsonia iner-
tion, a high concentration of leukocytes will appear in the connec- mis aqueous leaf extract which acted as a capping agent, are the
tive tissue of liver. Such signs of toxicity were not seen in the Ag & factors responsible for the potential biomedical application. The
ZnO treated mice and cell architecture is similar to that of control acute oral toxicity studies of biosynthesized Ag and ZnO nanopar-
mice. The brain image of Ag and ZnO nanoparticles treated mice ticles coated with active biocompounds of Lawsonia inermis leaf
was similar to that of control mice without any degeneration of extract for a period of 14 days showed no toxicity on tested mice.
neurons. The cardiac fiber of the heart tissue is normal without Additionally, the histopathological assessment revealed that syn-
any degeneration or fragmentation or hyalinization of muscle fiber thesized Ag and ZnO NPs are safe, nontoxic and biocompatible with
without congested blood vessels indicating that no toxicity is potential in treatment of various diseases. This study aims to prove
N. Jayarambabu et al. / Materials Letters 211 (2018) 43–47 47

that the biogenic synthesis of Ag and ZnO nanoparticles using Law- [2] L. Wang, J. Xie, T. Huang, Y. Ma, Z. Wu, Materi. Lett. 208 (2017) 126–129.
[3] S. Kaviya, S. Kabila, K.V. Jayasree, Mater. Lett. 204 (2017) 57–60.
sonia inermis leaf extract at the highest dose of 2000 mg/kg b.w
[4] Senthilkumar, E. NandhaKumar, P. Priya, D. Soni, M. Vimalan, I. Vetha
have not showed any toxicity during the study. The method Potheher, New J. Chem. (2017) 1–10.
choosed was very economical because we used only precursor [5] H. Colak, E. Karakose, F. Duman, Environ. Chem. Lett. 15 (2017) 547–552.
compared to chemical method of synthesis where more than one [6] Z. Zang, A. Nakamura, J. Temmyo, Optics Express 21 (2013) 11448–11456.
[7] Z. Zang, X. Zeng, J. Du, M. Wang, X. Tang, Opt. Lett. 14 (2016) 3463–3466.
chemical is needed for synthesis. I also want to prove that the [8] C. Li, C. Han, Y. Zhang, Z. Zang, M. Wang, X. Tang, J. Du, Sol. Energy Mater. Sol.
nanoparticles capped with plant extract can be used in major ther- Cells 172 (2017) 341–346.
apies because of its non-toxicity in acute oral toxicity studies. Tox- [9] V. Ravichandran, S. Vasanthi, S. Shalini, S.A.A. Shah, R. Harish, Mater. Lett. 180
(2016) 264–267.
icity results from animals will be crucial in definitively judging the [10] E.K. Baghkheirati, M.B.B. Najjar, Mater. Lett. 171 (2016) 166–170.
safety of medicinal plants if they are found to have sufficient [11] G. Sathishkumar, C. Rajkuberan, K. Manikandan, S. Prabukumar, S.
potential for development into pharmacological products. Sivaramakrishnan, Mater. Lett. 188 (2017) 383–386.
[12] M. Sundrarajan, S. Jegatheeswaran, S. Selvam, R. Gowri, K. Bharathi, Mater.
Lett. 201 (2017) 31–34.
Acknowledgement [13] A. Nordmeier, J. Woolford, L. Celeste, D. Chidambaram, Mater. Lett 191 (2017)
53–56.
[14] G. Madhubabu, Y. Suresh, Inhal. Toxicol. 24 (2012) 143–152.
One of the authors, N. Jayarambabu would like to thank CMR [15] G. Madhubabu, Y. Suesh, Environ. Toxicol. 29 (2014) 1330–1345.
College of Pharmacy, Hyderabad and CNST, IST, JNTUH for provid- [16] J. Zhou, G. Zhao, X. Ren, B. Song, G. Han, J. Sol-Gel Sci. Tehnol. 58 (2011) 148–
ing lab and instrumentation facility. 155.
[17] M.G. Guzmán, J. Dille, S. Godet, Int. J. Chem. Biomol. Eng. 2 (2009) 104–111.
[18] A. Khamhaengpol, S. Siri, Mater. Lett. 192 (2017) 72–75.
References [19] J. Du, T.H. Yi, Mater. Lett. 178 (2016) 75–78.
[20] K. Shanker, G.K. Mohan, V. Mayasa, L. Pravallika, Mater. Lett. 195 (2017) 240–
[1] M.N. Gallucci, J.C. Fraire, A.P.V.F. Maillard, P.L. Paez, et al., Mater. Lett. 197 244.
(2017) 98–101.

You might also like